Get started
Author

Koenraad Dierick

Observed names: DIERICK K., K Dierick, K. Dierick
Institution: Terumo (Belgium)
ORCID: 0000-0003-2193-4235
Observed ORCID: 0000-0003-2193-4235
OpenAlex ID: A5083536558
Quality of life in people with sickle cell disease treated with automated red blood cell exchange
2024 · Koenraad Dierick, Beatriz Rodriguez‐Grande, et al. · Vox Sanguinis · 6
PDF
POSC296 Whole Blood Processing Systems: An Analysis on the Differences Between Automated Blood Processing System and the Bottom-to-Top Semiautomated Blood Processing System
2022 · N. Comasòlivas, K. Dierick, et al. · Value in Health · 4
PDF
5567917 Cost Comparison of Transfusion Choices in Oman for Patients Suffering From Sickle Cell Disease
2023 · L. Sweerts, S. Al Kindi, et al. · HemaSphere · 2
Measuring Health-Related Quality of Life in Sickle Cell Disease Patients Undergoing Automated Red Blood Cell Exchange in the USA, France and the UK
2018 · Koenraad Dierick, Joseph Roig · Blood · 2
PCR45 Vascular Access Devices: A Comparative Analysis of Complications and Their Cost Implications
2023 · H. Bouguerra, F. Waltl, et al. · Value in Health · 1
PDF
EPH148 Disease Burden of Sickle Cell Disease in Saudi Arabia
2023 · H. Bouguerra, F. Waltl, et al. · Value in Health · 1
PDF
PNS12 Can a Reusable Surgical Face Mask Bring Health Economic and Ecological Benefit to a Health System upon the Outbreak of an Emerging Pathogen?
2021 · K. Dierick · Value in Health · 1
PDF
Pnd90 Application of Big Data in Rare Disease Management: Treatment Cost of Therapeutic Plasma Exchange Versus Immunoglobulins in an Outpatient Setting
2019 · K. Dierick, A. Silver · Value in Health · 1
Pmd12 How Much Can Colombian Hospitals Earn for Each Therapeutic Plasma Exchange (tpe) Procedure? a Multi-center, Cost Comparison Study Between Centrifugal and Membrane Systems
2019 · N. Comasòlivas, K. Dierick, et al. · Value in Health Regional Issues · 1
Pmd21 Cost Benefit Analysis for Centrifugal Versus Membrane-based Therapeutic Plasma Exchange
2019 · K. Dierick, N. Comasòlivas, et al. · Value in Health · 1
Pmd20 Centrifugal Versus Membrane Therapeutic Plasma Exchange: Single Center Cost Benefit Analysis in Thailand
2019 · Y. Lee, M. Apiwattanakul, et al. · Value in Health · 1
Latest Insights on the Cost Efficiency of Therapeutic Plasma Exchange in Treating Guillain-Barre Syndrome
2018 · K Dierick · Value in Health · 1
Assessing Willigness to Pay Among Psoriasis and Psoriatic Arthritis Patients
2014 · K. Dierick, A. Rose · Value in Health · 1
PCR100 Vascular Access Adverse Events: A Comprehensive Literature Review and Comparative Analysis
2023 · H. Bouguerra, F. Waltl, et al. · Value in Health
EE399 Assessing the Risks and Benefits Associated with Automation during Cell Expansion Processes at Cell and Gene Therapy Manufacturers
2023 · K. Dierick · Value in Health
PDF
Process Development and Manufacturing: AN ASSESSMENT OF THE RISKS, BENEFITS AND COSTS ASSOCIATED WITH CELL EXPANSION AND THE FILL AND FINISH PROCESS FOR CELL AND GENE THERAPY MANUFACTURERS
2023 · K. Dierick, H. Fabre, et al. · Cytotherapy
P-072: Cost Comparison of Transfusion Choices in Oman for Patients Suffering From Sickle Cell Disease.
2022 · AL KINDI S., AL HASHAMI S., et al. · HemaSphere
EE170 Implementation of an Evidence-Based, Software Application to Compare Automation Blood Processing Systems (ABPS) Vs. Semi-Automated Blood Processing Systems
2022 · N Comasòlivas, K Dierick · Value in Health
POSC153 Long-Term Cost Efficiencies Linked to Automated vs. Manual Fill and Finish Process in Cell and Gene Therapy Manufacturing
2022 · T Rezi-Kato, K Dierick · Value in Health
POSB297 Assessing the Cost and Value Drivers of Automation in Cell and Gene Therapy Manufacturing: A Decision Guide
2022 · T. Rezi-Kato, K. Dierick · Value in Health
Health care economic evaluation of fill and finish system in cell and gene therapy manufacturing
2021 · A. Silver, M. Walsleben, et al. · Cytotherapy
Health Economic Value of Blood in Kenya, Ghana and Ivory Coast: The Case of Maternal Bleeding
2021 · S. Owusu-Ofori, Y.M. Sekongo, et al. · Africa Sanguine
PDF
PMD7 A Stakeholder Perspective on the Health Economic Cost of Sickle Cell Disease in Function of Preferred Transfusion Modality
2020 · K. Dierick, L. Sweerts · Value in Health
PMD13 A Health Economic Evaluation of the Impact of Pathogen Reduction Technology on Emerging Pathogens within the Platelet Collection and Transfusion Space
2020 · K. Dierick, L. Sweerts, et al. · Value in Health
PMD11 Can Blood Units Coming from Whole Blood Automation Deliver a Clinically Meaningful Difference to Anemic Patients Versus Alternative Blood Collection Types?
2020 · A.I. Pérez Aliaga, M. Cardoso, et al. · Value in Health
PDF
Works count: 50
Citation count: 23
H-index: 2
I10-index:
Year
Topic
Type